Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Elocon vs Fluticasone in Localized Psoriasis

Trial Profile

Elocon vs Fluticasone in Localized Psoriasis

Phase of Trial: Phase IV

Latest Information Update: 29 Sep 2017

At a glance

  • Drugs Mometasone (Primary) ; Fluticasone propionate
  • Indications Psoriasis
  • Focus Therapeutic Use
  • Acronyms P03197
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 29 Sep 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top